Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Levodopa Induced Dyskinesia”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Not applicableUnknownNCT04173832
What this trial is testing

Clinical Study on Treatment of L-DOPA-Induced Dyskinesia With Tianqi Pingchan Granule Combined With Amantadine

Who this might be right for
L-DOPA-Induced Dyskinesia
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 100
Testing effectiveness (Phase 2)Study completedNCT01474421
What this trial is testing

Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease

Who this might be right for
DyskinesiasDrug-induced
Novartis Pharmaceuticals 71
Testing effectiveness (Phase 2)Study completedNCT00314288
What this trial is testing

Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia

Who this might be right for
Parkinson's DiseaseDyskinesia
EMD Serono 360
Not applicableStudy completedNCT01429207
What this trial is testing

Capturing Parkinson's Disease Medication Side Effects During Daily Activities

Who this might be right for
Parkinson's DiseaseDyskinesia
Great Lakes NeuroTechnologies Inc. 15
Testing effectiveness (Phase 2)Study completedNCT01491529
What this trial is testing

Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Who this might be right for
DyskinesiasParkinson DiseaseMovement Disorders+2 more
Novartis Pharmaceuticals 154
Testing effectiveness (Phase 2)Study completedNCT01538329
What this trial is testing

Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease

Who this might be right for
Parkinson Disease
University Hospital, Toulouse 210
Large-scale testing (Phase 3)Study completedNCT02274766
What this trial is testing

Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia

Who this might be right for
DyskinesiaLevodopa-Induced Dyskinesia (LID)Parkinson's Disease (PD)
Adamas Pharmaceuticals, Inc. 77
Early research (Phase 1)UnknownNCT06021756
What this trial is testing

Phase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson's Disease

Who this might be right for
Levodopa-Induced DyskinesiaParkinson's Disease
University of Arizona 9
Not applicableStudy completedNCT00912977
What this trial is testing

Prospective Evaluation of Forceplate Measured Levodopa-Induced Dyskinesia

Who this might be right for
Parkinson's Disease
Oregon Health and Science University 10
Post-approval studies (Phase 4)Ended earlyNCT00477802
What this trial is testing

Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease

Who this might be right for
Parkinson Disease
University of Cincinnati 8
Large-scale testing (Phase 3)Study completedNCT02202551
What this trial is testing

Open-Label Safety Study of ADS-5102 in PD Patients With LID

Who this might be right for
DyskinesiaLevodopa Induced Dyskinesia (LID)Parkinson's Disease (PD)
Adamas Pharmaceuticals, Inc. 223
Large-scale testing (Phase 3)Study completedNCT02136914
What this trial is testing

ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)

Who this might be right for
DyskinesiaLevodopa Induced Dyskinesia (LID)Parkinson's Disease
Adamas Pharmaceuticals, Inc. 126
Testing effectiveness (Phase 2)Study completedNCT01173731
What this trial is testing

Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedLevodopa
Novartis Pharmaceuticals 66
Testing effectiveness (Phase 2)UnknownNCT02439125
What this trial is testing

Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Disease Patients

Who this might be right for
Parkinson's DiseaseDyskinesia
Amarantus BioScience Holdings, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT00160576
What this trial is testing

Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias

Who this might be right for
Idiopathic Parkinson Disease
UCB Pharma 30
Large-scale testing (Phase 3)Ended earlyNCT05116813
What this trial is testing

Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedDyskinesias
Addex Pharma S.A. 17
Testing effectiveness (Phase 2)Study completedNCT03368170
What this trial is testing

Efficacy and Tolerability of IRL790 in Parkinson's Disease Dyskinesia

Who this might be right for
Parkinson Disease
Integrative Research Laboratories AB 75
Not applicableStudy completedNCT00467597
What this trial is testing

Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)

Who this might be right for
DyskinesiasMovement DisordersParkinson Disease
US Department of Veterans Affairs 36
Testing effectiveness (Phase 2)Looking for participantsNCT05766813
What this trial is testing

Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease

Who this might be right for
Parkinson Disease
Intra-Cellular Therapies, Inc. 132
Testing effectiveness (Phase 2)Study completedNCT00036296
What this trial is testing

Effects of Talampanel on Patients With Advanced Parkinson's Disease

Who this might be right for
DyskinesiasParkinson DiseaseMovement Disorders
Teva Branded Pharmaceutical Products R&D, Inc. 22
Load More Results